Good product, great management but too much stock on issue, needs a 1:5 or 1:10 capital restructure big time.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
